Health Care Industry Forecasts - China Focus

  • ID: 3397822
  • Report
  • Region: China
  • 124 pages
  • AMID Co
50 % OFF
until Dec 31st 2018
1 of 4
China's demand for Health Care will continue to grow at about 11% by 2027
This study focuses on China’s Health Care industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study focuses on industry trends and forecasts with historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases.

The author is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. They have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. The report provides hard-to-find market data and analyses. The publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

Overview
Medical Treatment Revenues and Forecasts by Region
Northeast
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
North
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Southeast
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Central South
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Southwest
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Northwest
Hospitals
Physicians
Hospital Visits
Medical Treatment Revenues
Medical Supplies Production and Demand
Major Producers
Total Output and Demand
Foreign Trade
Pricing Trends
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest

Northwest
Pharmaceuticals Production and Demand
Major Producers
Total Output and Demand
Foreign Trade
Pricing Trends
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest

Northwest
Medical Equipment Production and Demand
Major Producers
Total Output and Demand
Foreign Trade
Pricing Trends
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest

Northwest

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

The Total Health Care Output And Demand
The Amount Of Hospitals In Northeast
The Amount Of Physicians In Northeast
The Amount Of Hospital Visits In Northeast
The Medical Treatment Revenues In Northeast
The Amount Of Hospitals In North
The Amount Of Physicians In North
The Amount Of Hospital Visits In North
The Medical Treatment Revenues In North
The Amount Of Hospitals In Southeast
The Amount Of Physicians In Southeast
The Amount Of Hospital Visits In Southeast
The Medical Treatment Revenues In Southeast
The Amount Of Hospitals In Central South
The Amount Of Physicians In Central South
The Amount Of Hospital Visits In Central South
The Medical Treatment Revenues In Central South
The Amount Of Hospitals In Southwest
The Amount Of Physicians In Southwest
The Amount Of Hospital Visits In Southwest
The Medical Treatment Revenues In Southwest
The Amount Of Hospitals In Northwest
The Amount Of Physicians In Northwest
The Amount Of Hospital Visits In Northwest
The Medical Treatment Revenues In Northwest
The Major Producers Of Medical Supplies
The Total Medical Supplies Output And Demand
The Foreign Trade Of Medical Supplies
The Medical Supplies Output And Demand In Northeast
The Medical Supplies Output And Demand In North
The Medical Supplies Output And Demand In Southeast
The Medical Supplies Output And Demand In Central South
The Medical Supplies Output And Demand In Southwest
The Medical Supplies Output And Demand In Northwest
The Major Producers Of The Pharmaceuticals
The Pharmaceuticals Total Output And Demand
The Foreign Trade Of The Pharmaceuticals
The Pharmaceuticals Output And Demand In Northeast
The Pharmaceuticals Output And Demand In North
The Pharmaceuticals Output And Demand In Southeast
The Pharmaceuticals Output And Demand In Central South
The Pharmaceuticals Output And Demand In Southwest
The Pharmaceuticals Output And Demand In Northwest
The Major Producers Of Medical Equipments
The Medical Equipment Total Output And Demand
The Foreign Trade Of The Medical Equipment
The Medical Equipment Output And Demand In Northeast
The Medical Equipment Output And Demand In North
The Medical Equipment Output And Demand In Southeast
The Medical Equipment Output And Demand In Central South
The Medical Equipment Output And Demand In Southwest
The Medical Equipment Output And Demand In Northwest

LIST OF CHARTS

I. INTRODUCTION

China’s Health Care Industry Output and Demand

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. HEALTH CARE INDUSTRY OUTPUTS AND FORECASTS

the Medical Goods Output and Demand
the Total Medical Supplies Output and Demand
the Pharmaceuticals Total Output and Demand
the Medical Equipment Total Output and Demand
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4


Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.

Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll